<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_DTU_Denmark_applications"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu"><UL><LI class="selected"><A href="/Team:DTU_Denmark/applications">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:DTU_Denmark/applications&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:DTU_Denmark/applications&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:DTU_Denmark/applications&amp;action=history">History               </A></LI><LI style="color:#808080;cursor:default">teams</LI></UL></DIV><DIV class="right-menu" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:DTU_Denmark/applications" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:DTU Denmark/applications</H1><DIV id="bodyContent"><H3 id="siteSub">From 2009.igem.org</H3><P><TITLE>Theoretical background</TITLE></P><TABLE class="links"><TBODY><TR><TD align="center"><FONT face="arial" size="3"><A class="mainLinks" href="https://2009.igem.org/Team:DTU_Denmark">Home</A></FONT></TD><TD align="center"><FONT face="arial" size="3"><A class="mainLinks" href="https://2009.igem.org/Team:DTU_Denmark/team">The Team</A></FONT></TD><TD align="center"><FONT face="arial" size="3"><A class="mainLinks" href="https://2009.igem.org/Team:DTU_Denmark/project">The Project</A></FONT></TD><TD align="center"><FONT face="arial" size="3"><A class="mainLinks" href="https://2009.igem.org/Team:DTU_Denmark/parts">Parts submitted</A></FONT></TD><TD align="center"><FONT face="arial" size="3"><A class="mainLinks" href="https://2009.igem.org/Team:DTU_Denmark/modelling">Modelling</A></FONT></TD><TD align="center"><FONT face="arial" size="3"><A class="mainLinks" href="https://2009.igem.org/Team:DTU_Denmark/notebook" title="Day to day lab activity">Notebook</A></FONT></TD></TR></TBODY></TABLE><TABLE><TABLE cellpadding="10px"><TBODY><TR><TD width="163px" height="100%" valign="top"><P><FONT color="#990000" face="arial" size="3"> 
   The redoxilator</FONT></P><FONT color="" face="arial" size="2"><A href="https://2009.igem.org/Team:DTU_Denmark/genetic_design" class="leftbar">- Genetic design</A><A href="https://2009.igem.org/Team:DTU_Denmark/applications" class="leftbar">- Applications and perspectives</A><A href="https://2009.igem.org/Team:DTU_Denmark/safety" class="leftbar">- Safety considerations</A></FONT><P><FONT color="#990000" face="arial" size="3">The USER assembly standard</FONT></P><FONT face="arial" size="2"><A href="https://2009.igem.org/Team:DTU_Denmark/USERprinciple" class="leftbar">- USER fusion of biobricks</A></FONT><P><FONT color="#990000" face="arial" size="3">USER fusion primer design software</FONT></P><FONT face="arial" size="2"><A href="https://2009.igem.org/Team:DTU_Denmark/USERprogram" class="leftbar">- Abstract</A><A href="https://2009.igem.org/Team:DTU_Denmark/USERprograminstructions" class="leftbar">- Instructions</A><A href="https://2009.igem.org/Team:DTU_Denmark/USERprogramoutputformat" class="leftbar">- Output format</A></FONT><P><FONT color="#990000" face="arial" size="3">Experimental results</FONT></P><FONT face="arial" size="2"><A href="https://2009.igem.org/Team:DTU_Denmark/results" class="leftbar">- Results and discussion</A></FONT></TD><TD width="556px" height="100%" valign="top"><FONT color="#990000" face="arial" size="5"><B>The project</B></FONT><FONT color="#333333" face="arial" size="2.5"><FONT size="4"><B>Applications and perspectives</B></FONT><P align="justify">
There are numerous potential applications for our genetic device, but here we have highlighted three key applications: an in vivo redox sensor, improved chemostat product formation and applications in cancer research.
</P><B><I>i) Reporter gene expression regulated by the Redoxilator – an in vivo redox sensor</I></B><P align="justify">The gene encoding green fluorescent protein (GFP) is widely used as a reporter gene in molecular biology. By placing the ROB promoter upstream of a GFP gene on a plasmid, and transforming the whole system into a yeast cell, GFP will be expressed at certain NAD<SUP>+</SUP>/NADH levels. When the REX-activator protein is bound to DNA, GFP expression will produce a visible and quantitatively measurable signal, which will be an indirect measure of the NAD<SUP>+</SUP>/NADH ratio.</P><DIV class="center"><DIV class="thumb tnone"><DIV class="thumbinner" style="width:502px;"><DIV class="thumbcaption"><B>In vivo online monitoring of the redox poise</B></DIV></DIV></DIV></DIV><P align="justify"><I> 
A Redoxilator plasmid can be transformed into any yeast cell to analyse the NAD<SUP>+</SUP>/NADH level by online measurement of reporter gene expression. The internal redox level of the cell is very indicative and have serious impact on product formation of many products</I>.</P><P align="justify">The measuring of cellular NAD<SUP>+</SUP>/NADH levels is usually a difficult process, especially due to fast changes in NAD<SUP>+</SUP>/NADH ratio that can occur when a sample is taken and exposed to slightly new conditions. With this sensor system, the quantitative measurement of the reporter gene will provide a fast and reliable way to determine the NAD<SUP>+</SUP>/NADH ratio in vivo. The plasmid can be transformed into a yeast strain allowing the NAD<SUP>+</SUP>/NADH ratio to be continuously monitored. As an example this plasmid can be used to study whether an engineered yeast strain has an altered NAD<SUP>+</SUP>/NADH ratio. The plasmid can be transformed into different yeast strains (e.g. wild type versus an engineered strain or two production strains) and the NAD<SUP>+</SUP>/NADH ratio can be compared.</P><B><I>ii) Product formation regulated by the Redoxilator – an attempt to improve and prolong chemostat processes</I></B><P align="justify">When <I>S. cerevisiae</I> are grown continuously in a chemostat, the productivity of e.g. antibiotic or protein product gradually decreases [Personal correspondence with the fermentation industry]. This occurs during maximum production and is believed to be the result of metabolic adaption with reduced product formation as a consequence. The metabolic adaption is believed to occur because the cells are stressed by the extensive production. The cells will adapt to the new metabolic situation, which will gradually lead to lower production rates. This is highly undesirable in the biotech industry, as the chemostats will have to be restarted on a regular basis, which is costly and time consuming.</P><DIV class="center"><DIV class="thumb tnone"><DIV class="thumbinner" style="width:532px;"><DIV class="thumbcaption"><B>Simulation of a chemostat fermentation with the Redoxilator Production system</B></DIV></DIV></DIV></DIV><P align="justify"><I>
Changes in the NAD<SUP>+</SUP>/NADH ratio (<B>A:</B> top graph) lead to change in the Rex DNA binding affinity (<B>B:</B> middle graph) leading to controlled bursts of reporter gene expression (<B>C:</B> lower graph).</I></P><P align="justify">A strategy to lower the effect of the metabolic adaption could be to couple the protein productivity with our redox-sensing device. If the NAD<SUP>+</SUP>/NADH level vary over time,  it will lead to periodic burst of gene expression leading to product formation. Consequently the cells will have time to recover periodically from the metabolic stress that occurs during the protein production phase. There are many indications that this will lead to a prolonged effective chemostat operation, and ultimately higher accumulation of product before a costly restart of the chemostat is required.</P><P><I><B>iii) Yeast as a model organism for humans: Redoxilator in cancer research</B></I></P><P align="justify">Yeast is used as a model organism for humans in many research projects. As an example, studies of the yeast cell cycle have paved the way for most of the knowledge about the cell cycle in mammalian cells. As yeast has been widely used as a model organism for studying cancer an integrated tool for detecting a significant change in the redox potential would ease this research, especially because a rising NADH level is seen as a hallmark of carcinogenesis. 
  Another prospect is preliminary research of gene therapy with DNA coding for the REX-activator protein controlling the transcription of a cancer drug. As cancer cells have extreme NAD<SUP>+</SUP>/NADH levels, the drug would mostly be expressed in cancer cells, leaving most normal cells unharmed.
</P></FONT></TD><TD width="182px" height="100%" valign="top" bgcolor="DDDDDD" class="greybox"><FONT face="arial" size="2"><P align="left"><I>“Synthetic Biology is an art of engineering new biological systems that don’t exist in nature.”</I></P><P align="right"><I>-Paras Chopra &amp; Akhil Kamma</I></P><P>In nature, biological molecules work together in complex systems to serve purposes of the cell. In synthetic biology these molecules are used as individual functional units that are combined to form tailored systems exhibiting complex dynamical behaviour. From ‘design specifications’ generated from computational modelling, engineering-based approaches enables the construction of such new specified gene-regulatory networks. The ultimate goal of synthetic biology is to construct systems that gain new functions, and the perspectives of the technology are enormous. It has already been used in several medical projects and is predicted to play a major role in biotech-production and environmental aspects.</P></FONT></TD></TR></TBODY></TABLE><TABLE><TBODY><TR height="25px"><TD width="967px" valign="center" align="center"><FONT face="arial" size="1">
 Comments or questions to the team? Please <A href="mailto:igem@bio.dtu.dk" class="email">Email us</A> -- Comments of questions to webmaster? Please <A href="mailto:lronn@bio.dtu.dk" class="email">Email us</A></FONT></TD></TR></TBODY></TABLE><DIV class="printfooter">
Retrieved from &quot;<A href="http://2009.igem.org/Team:DTU_Denmark/applications">http://2009.igem.org/Team:DTU_Denmark/applications</A>&quot;</DIV><DIV id="footer-box"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:DTU_Denmark/applications" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:DTU_Denmark/applications" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:DTU_Denmark/applications&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:DTU_Denmark/applications&amp;oldid=167902" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2009.igem.org:Privacy_policy" title="2009.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2009.igem.org:General_disclaimer" title="2009.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></TABLE></DIV></DIV></DIV></BODY></HTML>